Suppr超能文献

多重聚合酶链反应与标准尿液培养用于诊断有急性膀胱炎症状女性的比较

Multiplex Polymerase Chain Reaction vs Standard Urine Culture in Women Presenting with Symptoms of Acute Cystitis.

作者信息

Bauer Hope H, Jarvis Melissa A, Hoffberg Emily A, Batur Ali F, Hojat Leila S, Hijaz Adonis K, Sheyn David

机构信息

Urology Institute, Division of Urogynecology, University Hospitals of Cleveland, Cleveland, OH, USA.

Department of Obstetrics and Gynecology, University Hospitals of Cleveland, Cleveland, OH, USA.

出版信息

Int Urogynecol J. 2025 Sep 5. doi: 10.1007/s00192-025-06295-8.

Abstract

INTRODUCTION AND HYPOTHESIS

Prior studies suggest that acute cystitis diagnosis using standard urine culture (SUC) may be suboptimal compared to multiplex polymerase chain reaction (mPCR). mPCR is hypothesized to deliver faster and more accurate results.

METHODS

This was a prospective, paired, within-subject study of female patients ≥ 60 years presenting with symptoms of acute cystitis. For all patients, urine samples were collected and SUC and mPCR results using the Vikor Urine-ID™ platform were obtained. Initial treatment was based on the results of the first available test, either SUC or mPCR. The primary outcome was time from initial presentation to correct antibiotic therapy. Secondary outcomes included patient perception of symptoms, antibiotic regimen changes, and discordance between the test results.

RESULTS

A total of 87 patients were eligible for analysis. Overall, there were 36 positive SUC (41.4%) and 71 positive mPCR (81.6%) results. Discordant results were noted in 43.7% of patients, which lead to treatment changes in 33.3% of patients. The time to correct antibiotic therapy was not significantly different based on initial treatment choice test (mPCR 67.0 h vs SUC 78.2 h, p = 0.16). However, in the case of positive SUC, the time to correct antibiotic therapy was significantly shorter for mPCR (mPCR 64.8 h vs SUC 79.5 h, p = 0.02). Non-Escherichia coli species, specifically Enterococcus faecalis, were more likely to be identified on mPCR (43.7%) than on SUC (8.3%), p < 0.001.

CONCLUSIONS

mPCR may be an effective method of identifying urinary pathogens in symptomatic patients, particularly those with non-Escherichia coli species.

摘要

引言与假设

先前的研究表明,与多重聚合酶链反应(mPCR)相比,使用标准尿培养(SUC)诊断急性膀胱炎可能并不理想。据推测,mPCR能提供更快、更准确的结果。

方法

这是一项针对年龄≥60岁、有急性膀胱炎症状的女性患者的前瞻性、配对、受试者内研究。对所有患者收集尿液样本,并使用Vikor Urine-ID™平台获得SUC和mPCR结果。初始治疗基于首次可用检测(SUC或mPCR)的结果。主要结局是从初次就诊到正确抗生素治疗的时间。次要结局包括患者对症状的感知、抗生素治疗方案的改变以及检测结果之间的不一致。

结果

共有87例患者符合分析条件。总体而言,SUC结果阳性的有36例(41.4%),mPCR结果阳性的有71例(81.6%)。43.7%的患者出现结果不一致的情况,其中33.3%的患者因此改变了治疗方案。根据初始治疗选择检测方法,正确抗生素治疗的时间无显著差异(mPCR为67.0小时,SUC为78.2小时,p = 0.16)。然而,在SUC结果为阳性的情况下,mPCR的正确抗生素治疗时间显著更短(mPCR为64.8小时,SUC为79.5小时,p = 0.02)。非大肠杆菌菌种,特别是粪肠球菌,在mPCR中被识别的可能性(43.7%)高于SUC(8.3%),p < 0.001。

结论

mPCR可能是一种识别有症状患者尿路病原体的有效方法,尤其是对于那些感染非大肠杆菌菌种的患者。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验